PURPLE URINE BAG SYNDROME- AN INTERESTING AND RARE PHENOMENON

S. DESHKAR¹*, S. RAUT², S. KHANTE^3
1Department of Microbiology, Indira Gandhi Government Medical College and Hospital, Nagpur, 440018, Maharashtra University of Health Sciences, Nashik, 422004, India
²Department of Microbiology, Indira Gandhi Government Medical College and Hospital, Nagpur, 440018, Maharashtra University of Health Sciences, Nashik, 422004, India
³Department of Microbiology, Indira Gandhi Government Medical College and Hospital, Nagpur, 440018, Maharashtra University of Health Sciences, Nashik, 422004, India
* Corresponding Author : smitadeshkar@ymail.com

Received : 12-07-2018     Accepted : 23-07-2018     Published : 30-07-2018
Volume : 10     Issue : 7       Pages : 1303 - 1305
Int J Microbiol Res 10.7 (2018):1303-1305

Keywords : Purple urine bag syndrome, Tryptophan, Catheterization, Antibiotic therapy
Conflict of Interest : None declared
Acknowledgements/Funding : Author thankful to Indira Gandhi Government Medical College and Hospital, CA Road, Nagpur, 440018, Maharashtra University of Health Sciences, Nashik, 422004, India
Author Contribution : All author equally contributed

Purple urine bag syndrome (PUBS) is a unique disease entity characterized by an alarming purple discoloration of the urine secondary to recurrent urinary tract infections with indigo- and indirubin-producing bacteria. It is usually associated with prolonged urinary catheterization and chronic debilitated states. We present this interesting phenomenon of purple urine in an elderly bedridden female who was on prolonged urinary catheterization. The urine culture was positive for E.coli and constipation was an added risk factor for the purple urine. The urinary catheter and tubing was changed along with a course of antibiotics which lead to the normalization of the urine colour.

1. Khan F., Chaudhry M.A., Qureshi N., Cowley B. (2011) Int J Nephrol, 2011, 419213.
2. Arnold W.N. (1996) Lancet ,347,1811-3.
3. Barlow G.B., Dickson J.A. (1978) Lancet, 311,220-1.
4. Su Y.J., Lai Y.C., Chang W.H. (2007) Am J Emerg Med, 25(861),e5–6.
5. Su F.H., Chung S.Y., Chen M.H., Sheng M.L., Chen C.H., Chen Y.J., et al. (2005) Chang Gung Med J, 28, 636-42.
6. Kalsi D.S., Ward J., Lee R., Handa A. (2017) Disease Markers, Article ID 9131872.
7. Shiao C.C., Weng C.Y., Chuang J.C., Huang M.S., Chen Z.Y. (2008) Nephrology, 13(7), 554-59.
8. Umeki S. (1993) Kansenshogaku Zasshi, 67(12), 1172-1177.
9. ChungS.D., Liao C.H., Sun H.D. (2008) Int Infect Dis ,12, 526-7.
10. Ficher K.N., Neves A.A., Gomes S., Lins P.R.G., Silva M.J., Góis A.F. (2016) Brazilian J Nephrol, 38(4), 470- 472.
11. Hadano Y., Shimizu T., Takada S., Inoue T., Sorano S. (2012) Int J Gen Med, 5, 707-10.
12. Weaver J.C., Rajakunjaram R.K., Gunawardena I.A.A. (2018) Int J Case Rep Images, 9(1), 63-65.
13. Pillai B.P., Chong V.H., Yong A.M. (2009) Singapore Med J. 50(5),e193-4.
14. Gebrmichael T., Feleke F., Ahmed W., Urella M., Teka S. (2017) Marshall J Med, 3(3), Article 6.